On Friday April 17, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Methods and Compositions for Adoptive Cell Therapy” to Lyell Immunopharma, Inc. (85 FR… Continue Reading →
Today, the Office of the United States Trade Representative hosted the hearing for the annual Special 301 Review. The review process includes a solicitation of written comments and hearing testimony, and results in the publication of the Special 301 Report.… Continue Reading →
On Tuesday, 1 October 2019, Knowledge Ecology International delivered the following opening statement at the 2019 WIPO General Assembly. Thank you Chair. KEI opposes any further work at the SCCR on a broadcast treaty, given the confusion over the objectives… Continue Reading →
On Monday, 24 June 2019, Knowledge Ecology International (KEI) delivered this opening statement at WIPO’s 30th Session of the Standing Committee on the Law of Patents (SCP). The Committee elected a new chair, Sarah Whitehead, United Kingdom of Great Britain… Continue Reading →
One of the reasons why drug companies have fought so hard to block transparency of clinical trial costs is the growing gap between what the public had been told those costs are, and the actual costs, particularly for treatments for… Continue Reading →
On Wednesday May 22, 2019, KEI delivered the following intervention at the 72nd World Health Assembly for the agenda item, “11.5 – Universal Health Coverage.” A PDF version is available here. KEI Statement – WHA72 11.5 – Universal Health Coverage… Continue Reading →
Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and… Continue Reading →
We now keep track of our FOIA requests here. Recent NIH FOIAs: https://www.keionline.org/foia/nih Older logs and pages about selected Freedom of Information Act (FOIA) requests filed by KEI. Centers for Disease Control and Prevention (CDC) March 3, 2015: CDC FOIA… Continue Reading →
On April 30, 2019, KEI issued a memorandum to Congress concerning recent proposed measures to cap drug price increases and to increase the transparency of pharmaceutical research and development costs. Congress is currently considering several bills that touch on these… Continue Reading →
On Monday, 1 April 2019, Knowledge Ecology International (KEI) delivered the following oral statement to the Open Session of the 22nd Meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines. The program for the open… Continue Reading →